DK3502125T5 - Peptider og fremgangsmåder til detektering af LYME-sygdomsantifstoffer - Google Patents
Peptider og fremgangsmåder til detektering af LYME-sygdomsantifstoffer Download PDFInfo
- Publication number
- DK3502125T5 DK3502125T5 DK19150770.6T DK19150770T DK3502125T5 DK 3502125 T5 DK3502125 T5 DK 3502125T5 DK 19150770 T DK19150770 T DK 19150770T DK 3502125 T5 DK3502125 T5 DK 3502125T5
- Authority
- DK
- Denmark
- Prior art keywords
- peptides
- methods
- lyme disease
- disease antibodies
- detecting lyme
- Prior art date
Links
- 208000016604 Lyme disease Diseases 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161556061P | 2011-11-04 | 2011-11-04 | |
| EP12846033.4A EP2773654A4 (en) | 2011-11-04 | 2012-11-05 | PEPTIDES AND METHODS FOR DETECTION OF ANTIBODIES OF LYME DISEASE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3502125T3 DK3502125T3 (da) | 2023-12-04 |
| DK3502125T5 true DK3502125T5 (da) | 2024-09-02 |
Family
ID=48192911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19150770.6T DK3502125T5 (da) | 2011-11-04 | 2012-11-05 | Peptider og fremgangsmåder til detektering af LYME-sygdomsantifstoffer |
Country Status (11)
| Country | Link |
|---|---|
| US (7) | US8758772B2 (enExample) |
| EP (3) | EP3502125B1 (enExample) |
| JP (3) | JP6839485B2 (enExample) |
| KR (3) | KR102503883B1 (enExample) |
| CN (1) | CN103998459A (enExample) |
| CA (1) | CA2851540C (enExample) |
| DK (1) | DK3502125T5 (enExample) |
| ES (1) | ES2967710T3 (enExample) |
| FI (1) | FI3502125T3 (enExample) |
| PL (1) | PL3502125T3 (enExample) |
| WO (1) | WO2013067524A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140186861A1 (en) * | 2011-07-11 | 2014-07-03 | Uvic Industry Partnerships Inc. | Soluble treponema pallidum protein tp0453, tp0453-tp0326 fusion protein, and use in syphilis diagnosis |
| US8758772B2 (en) | 2011-11-04 | 2014-06-24 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
| DK3489685T3 (da) | 2011-11-21 | 2023-12-04 | Zoetis Services Llc | Signalforstærkning i sidestrømning og tilsvarende immunoassays |
| US10294531B2 (en) | 2013-10-07 | 2019-05-21 | University Of Central Florida Research Foundation, Inc. | Method, kits and materials for detection of Lyme disease Borrelia sp. infection |
| US9194870B2 (en) | 2014-01-21 | 2015-11-24 | Abaxis, Inc. | Peptides, devices, and methods for the detection of Anaplasma antibodies |
| WO2015148609A2 (en) * | 2014-03-26 | 2015-10-01 | Li-Cor, Inc. | Immunoassays using colloidal crystals |
| US10274491B2 (en) | 2014-07-07 | 2019-04-30 | Veramarx, Inc. | Biomarker signatures for lyme disease and methods of use thereof |
| TWI691716B (zh) | 2014-08-13 | 2020-04-21 | 美商艾巴希斯公司 | 電漿特異性結合搭配物檢定中之信號放大 |
| US11061028B2 (en) | 2014-09-24 | 2021-07-13 | Defined Diagnostics, Llc | Compositions and methods for the diagnosis of lyme disease |
| EP4465021A3 (en) | 2015-08-04 | 2025-02-26 | Zoetis Services LLC | Signal amplification in solution-based plasmonic specific-binding partner assays |
| WO2017035389A1 (en) * | 2015-08-27 | 2017-03-02 | Quidel Corporation | Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes |
| LT3353551T (lt) | 2015-09-25 | 2023-02-10 | Qiagen Sciences, Llc | Kompozicijos ir būdai, skirti laimo ligos diagnozavimui ir laimo ligą sukeliančių spirochetų eliminacijos po gydymo nuspėjimui |
| EP3359558B1 (en) | 2015-10-06 | 2023-12-13 | Bio-Rad Laboratories, Inc. | Borrelia immunoassays and materials therefor |
| EP3400441A4 (en) | 2016-01-06 | 2019-12-25 | Veramarx, Inc. | SIGNATURES OF BIOMARKERS FOR THE DIFFERENTIATION OF LYME DISEASE AND METHODS OF USE THEREOF |
| EP3252470B1 (en) * | 2016-06-03 | 2020-07-29 | Te?ted Oy | A method and a solid support for detecting tick-borne microbes in a biological sample |
| US20170370925A1 (en) * | 2016-06-27 | 2017-12-28 | Tgr Biosciences Pty Ltd. | Lateral Flow Analyte Detection |
| CN106397589A (zh) * | 2016-10-31 | 2017-02-15 | 杭州贝英福生物科技有限公司 | 一种狭义伯氏疏螺旋体多克隆抗体及应用 |
| CN106432487A (zh) * | 2016-10-31 | 2017-02-22 | 杭州贝英福生物科技有限公司 | 一种伽氏疏螺旋体多克隆抗体及应用 |
| KR102486615B1 (ko) | 2017-01-30 | 2023-01-11 | 조에티스 서비시즈 엘엘씨 | 용액-기반 플라스몬 특이적-결합 파트너 검정 및 금속성 나노구조체 |
| CN106932567B (zh) * | 2017-02-27 | 2018-10-30 | 天津市泌尿外科研究所 | 一种重组蛋白a介导的免疫靶向纳米金的制备方法 |
| US11331019B2 (en) | 2017-08-07 | 2022-05-17 | The Research Foundation For The State University Of New York | Nanoparticle sensor having a nanofibrous membrane scaffold |
| EP3688010A4 (en) * | 2017-09-25 | 2021-08-18 | The Trustees of Columbia University in the City of New York | SEROLOGICAL ASSAY FOR THE DETECTION OF EXPOSURE TO AND INFECTION BY TICKS-CARRIED PATHOGENIC AGENTS |
| CN109596824A (zh) * | 2019-01-04 | 2019-04-09 | 杭州奥泰生物技术股份有限公司 | 一种快速诊断莱姆病的检测试纸及其制备方法 |
| US10928394B2 (en) | 2019-02-07 | 2021-02-23 | Julian R. K. Kage | Rapid test for lyme bacteria |
| CN111018998B (zh) * | 2019-12-04 | 2021-10-29 | 杭州傲锐生物医药科技有限公司 | 一种莱姆重组融合蛋白OspC-VlsE及其应用 |
| JP2022165900A (ja) * | 2021-04-20 | 2022-11-01 | 株式会社デンソー | 分析方法 |
| EP4220166A1 (en) * | 2022-02-01 | 2023-08-02 | Universitat Rovira I Virgili (URV) | In vitro method for detecting antibodies in a sample |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4366246A (en) | 1977-11-08 | 1982-12-28 | Genentech, Inc. | Method for microbial polypeptide expression |
| US4888276A (en) | 1986-06-26 | 1989-12-19 | Minnesota Mining And Manufacturing Company | Method and composition for the diagnosis of Lyme disease |
| US4721617A (en) | 1986-08-14 | 1988-01-26 | Regents Of The University Of Minnesota | Vaccine against lyme disease |
| US5385826A (en) | 1989-04-21 | 1995-01-31 | Gundersen Medical Foundation, Ltd. | Diagnostic assay for lyme disease |
| DE4015911A1 (de) | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
| US5187065A (en) | 1989-12-22 | 1993-02-16 | Schutzer Steven E | Method and materials for detecting lyme disease |
| SG122738A1 (en) | 1990-06-15 | 2006-06-29 | Univ Yale | Compositions and methods for the prevention and diagnosis of lyme disease |
| US5155022A (en) | 1991-02-08 | 1992-10-13 | Becton, Dickinson And Company | Assay for lyme disease |
| US5324630A (en) | 1991-06-28 | 1994-06-28 | The Regents Of The University Of California | Methods and compositions for diagnosing lyme disease |
| US6221363B1 (en) | 1991-07-11 | 2001-04-24 | Baxter Aktiengesellschaft | Vaccine for the prevention of lyme disease |
| WO1993003184A1 (en) | 1991-08-09 | 1993-02-18 | Mccann Associates, Inc. | Method for detecting lyme disease and composition |
| US5965702A (en) | 1991-10-21 | 1999-10-12 | Abbott Laboratories | Borrelia burgdorferi antigens and uses thereof |
| US5618533A (en) | 1992-02-11 | 1997-04-08 | Yale University | Flagellin-based polypeptides for the diagnosis of lyme disease |
| US5308753A (en) | 1992-02-20 | 1994-05-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods for purifying and detecting IGM antibodies |
| US5620862A (en) | 1993-11-24 | 1997-04-15 | University Of Connecticut | Methods for diagnosing early Lyme disease |
| US5618333A (en) | 1995-03-28 | 1997-04-08 | Buchholz, Jr.; Leroy H. | Method for volatile organic compound recycling |
| US5932220A (en) | 1995-05-08 | 1999-08-03 | Board Of Regents University Of Texas System | Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov. |
| EP0894143B2 (en) | 1996-02-21 | 2012-04-18 | Board Of Regents, The University Of Texas System | Vmp-like sequences of pathogenic borrelia |
| US6716574B2 (en) | 1996-05-02 | 2004-04-06 | Dako A/S | Osp-C derived peptide fragments |
| US6902893B1 (en) | 1997-06-20 | 2005-06-07 | Gil H. Choi | Lyme disease vaccines |
| ES2270523T3 (es) | 1997-06-30 | 2007-04-01 | The Administrators Of The Tulane Educational Fund | Antigenos de superficie y proteinas utiles en composiciones para la diagnosis y prevencion de la enfermedad de lyme. |
| US6667038B1 (en) | 1999-04-21 | 2003-12-23 | Boston Medical Center Corp. | Prevention, diagnosis and treatment of lyme disease |
| US6475492B1 (en) | 1999-04-28 | 2002-11-05 | The Administrators Of The Tulane Educational Fund | Peptides and assays for the diagnosis of lyme disease |
| US6665652B1 (en) | 1999-07-28 | 2003-12-16 | Richard B. Porwancher | Method of diagnosis of lyme disease |
| US20030129680A1 (en) | 2001-10-31 | 2003-07-10 | O'connor Thomas Patrick | Multi-analyte assay device |
| CA2446246A1 (en) | 2001-05-03 | 2002-11-14 | Immunetics, Inc. | Systems and methods for detection of analytes in biological fluids |
| US6838247B2 (en) | 2002-06-19 | 2005-01-04 | Bowen Research And Training | Test for lyme disease |
| EP2292762A3 (en) | 2002-12-20 | 2012-12-12 | Board of Regents, The University of Texas System | VMP-like sequences of pathogenic Borrelia species and strains |
| US20060046310A1 (en) | 2004-08-25 | 2006-03-02 | Zong-Li Xia | Amplification method for solid phase immunoassays |
| US7390626B2 (en) | 2005-02-25 | 2008-06-24 | Immunosciences Lab., Inc. | Methods and kit for diagnosing tick borne illnesses |
| US8232045B2 (en) | 2005-03-29 | 2012-07-31 | Inverness Medical Switzerland Gmbh | Colloidal metal conjugates |
| WO2007133623A2 (en) | 2006-05-10 | 2007-11-22 | Biopeptides Corporation | Peptide diagnostic agent for lyme disease |
| US7776618B2 (en) | 2007-03-01 | 2010-08-17 | Church & Dwight Co., Inc. | Diagnostic detection device |
| US8399261B2 (en) | 2007-06-27 | 2013-03-19 | Inbios International, Inc. | Lateral flow assay system and methods for its use |
| EP2058663A1 (en) | 2007-11-12 | 2009-05-13 | Euro-Diagnostica B.V. | Method for the immobilization of an analyte on a solid support |
| JP2009236685A (ja) | 2008-03-27 | 2009-10-15 | Sysmex Corp | クロマトグラフィー用試験具 |
| WO2011063003A2 (en) * | 2009-11-17 | 2011-05-26 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
| US8758772B2 (en) | 2011-11-04 | 2014-06-24 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
-
2012
- 2012-11-02 US US13/667,909 patent/US8758772B2/en active Active
- 2012-11-05 FI FIEP19150770.6T patent/FI3502125T3/fi active
- 2012-11-05 ES ES19150770T patent/ES2967710T3/es active Active
- 2012-11-05 EP EP19150770.6A patent/EP3502125B1/en active Active
- 2012-11-05 WO PCT/US2012/063594 patent/WO2013067524A1/en not_active Ceased
- 2012-11-05 EP EP23206262.0A patent/EP4296673A3/en not_active Withdrawn
- 2012-11-05 KR KR1020197035277A patent/KR102503883B1/ko active Active
- 2012-11-05 KR KR1020237006043A patent/KR20230035134A/ko not_active Ceased
- 2012-11-05 KR KR1020147015224A patent/KR20140091735A/ko not_active Ceased
- 2012-11-05 CN CN201280062344.4A patent/CN103998459A/zh active Pending
- 2012-11-05 JP JP2014540187A patent/JP6839485B2/ja active Active
- 2012-11-05 EP EP12846033.4A patent/EP2773654A4/en not_active Ceased
- 2012-11-05 CA CA2851540A patent/CA2851540C/en active Active
- 2012-11-05 DK DK19150770.6T patent/DK3502125T5/da active
- 2012-11-05 PL PL19150770.6T patent/PL3502125T3/pl unknown
-
2014
- 2014-06-13 US US14/304,809 patent/US9201071B2/en active Active
-
2015
- 2015-10-27 US US14/924,358 patent/US9766238B2/en active Active
-
2017
- 2017-08-23 US US15/684,635 patent/US10073095B2/en active Active
-
2018
- 2018-09-10 US US16/126,419 patent/US10921321B2/en active Active
- 2018-10-09 JP JP2018190592A patent/JP2019048811A/ja active Pending
-
2020
- 2020-09-25 JP JP2020160834A patent/JP2021004251A/ja not_active Withdrawn
-
2021
- 2021-01-14 US US17/149,227 patent/US11573227B2/en active Active
-
2023
- 2023-01-03 US US18/149,612 patent/US20230228747A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3502125T5 (da) | Peptider og fremgangsmåder til detektering af LYME-sygdomsantifstoffer | |
| HUS2300021I1 (hu) | Anti-IL-36R antitestek | |
| DK2785375T3 (da) | Anti-pd-l1-antistoffer og anvendelser deraf | |
| EP2663857A4 (en) | METHOD OF DETECTION OF PROTEINS | |
| PL3415531T3 (pl) | Białka wiążące antygen | |
| DK2812443T3 (da) | Cd47-antistoffer og fremgangsmåder til anvendelse deraf | |
| HUE049457T2 (hu) | Módosított polipeptidek bispecifikus ellenanyag-vázhoz | |
| DK3556774T3 (da) | Anti-CD40-antistoffer og anvendelser deraf | |
| DK2766392T3 (da) | Fremgangsmåde til oprensning af antistoffer | |
| DK2668210T3 (da) | Anti-kit antistoffer og anvendelser deraf | |
| DK2768857T3 (da) | Fremgangsmåder til oprensning af antistoffer | |
| CO7020862A2 (es) | Proteinas de unión al antígeno cd27l | |
| DK2710033T3 (da) | Human immundefektvirus-neutraliserende antistoffer og fremgangsmåder til anvendelse deraf | |
| DK2925782T3 (da) | Anti-cd47-antistoffer og fremgangsmåder til anvendelse deraf | |
| HUE056808T2 (hu) | TGF-bétára specifikus antitestek | |
| DK3842456T3 (da) | Monoklonalt Interleukin-31-antistof | |
| DK3741883T5 (da) | Antistofbiblioteker | |
| DK2531526T3 (da) | Fremgangsmåde til opnåelse af antistoffer | |
| DK2673576T3 (da) | Indretning til at adskille dråber og en anvendelse af en sådan indretning | |
| DK2672979T3 (da) | Anti-cd4-antistoffer til forebyggelse af især graft-versus-host-sygdom (gvhd) | |
| HUE060312T2 (hu) | A JC vírus antitestek vizsgálata | |
| ITRM20120383A1 (it) | Metodo e kit per la rivelazione di anticorpi. | |
| BR112014001120A2 (pt) | métodos de separação de polipeptídeos | |
| EP2672272A4 (en) | Analysis device | |
| DK2621623T3 (da) | Apparatur og fremgangsmåder til fremstilling af faste perler |